Managing Myeloma
- 2016-05-03 - Ixazomib in First All-Oral Triplet for Multiple Myeloma
- 2016-05-02 - Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma
- 2016-05-02 - TJP1 protein may identify multiple myeloma patients most likely to benefit from proteasome inhibitors
- 2016-04-06 - NCCN Makes Major Changes to Multiple Myeloma Guidelines
- 2016-03-08 - Therapeutic Target for Myeloma Identified Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai - Drug Discovery & Development
- 2016-03-04 - Vulnerability Found in Blood Cancer Development Walter & Eliza Hall Institute of Medical Research - Drug Discovery & Development
- 2016-02-24 - Emory University, Winship Cancer Institute Names Sagar Lonial, MD, Managing Myeloma Continuing Education Initiative Advisory Group Member, Department Chairman - Healio HemOnc today
- 2016-02-15 - UK launch for Amgen's multiple myeloma drug carfilzomib - Pharma Times
- 2016-01-25 - FDA Expands Label for Carfilzomib in Multiple Myeloma - CancerNetwork
- 2016-01-24 - NCCN Updates Guidelines for Multiple Myeloma Version 3.2016
- 2015-11-30 - Breaking News: FDA approves Elotuzumab (Empliciti), a new immune-stimulating therapy to treat multiple myeloma
- 2015-11-25 - Alfred Goldberg, PhD, and Managing Myeloma Faculty member Paul Richardson, MD, to Present 2015 ASH Ernest Beutler Lecture and Receive Associated Prize
- 2015-11-20 - Breaking News: FDA approves Ixazomib [Ninlaro], new oral proteasome inhibitor to treat multiple myeloma
- 2015-11-16 - Breaking News: FDA approves Daratumumab [Darzalex] for patients with previously treated multiple myeloma
- 2015-10-19 - NCCN reveals new value initiative for CML and Multiple Myeloma - News Medical